Amyloidosis trials in Croatia

1 of 1 trials · From ClinicalTrials.gov, checked 13 November 2026. Ask the study team whether a trial fits you.

• No phaseTaking people
  A Study to Learn About the Use of Acoramidis in Patients With a Heart Condition Called Transthyretin Amyloid Cardiomyopathy (ATTR-CM) in a Real-world Setting

  Where

  Multiple Locations

  Age

  18 years and over

  People

  2,000 worldwide

  Run by

  Bayer

  See details and how to joinNCT07235462